{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T12:55:15Z","timestamp":1793278515896,"version":"4.5.0"},"reference-count":127,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.pharmthera.2016.06.009","type":"journal-article","created":{"date-parts":[[2016,6,28]],"date-time":"2016-06-28T09:14:47Z","timestamp":1467105287000},"page":"104-112","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":106,"special_numbering":"C","title":["Biologics and the lung: TSLP and other epithelial cell-derived cytokines in asthma"],"prefix":"10.1016","volume":"169","author":[{"given":"Patrick D.","family":"Mitchell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M.","family":"O'Byrne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.pharmthera.2016.06.009_bb0005","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1365-2249.2008.03731.x","article-title":"Human TSLP directly enhances expansion of CD8+ T cells","volume":"154","author":"Akamatsu","year":"2008","journal-title":"Clin Exp Immunol"},{"issue":"4","key":"10.1016\/j.pharmthera.2016.06.009_bb0010","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.4049\/jimmunol.179.4.2051","article-title":"Cutting edge: The ST2 ligand IL-33 potently activates and drives maturation of human mast cells","volume":"179","author":"Allakhverdi","year":"2007","journal-title":"J Immunol"},{"issue":"256","key":"10.1016\/j.pharmthera.2016.06.009_bb0015","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3010273","article-title":"IL-25: The missing link between allergy, viral infection, and asthma?","volume":"6","author":"Andreakos","year":"2014","journal-title":"Sci Transl Med"},{"issue":"11","key":"10.1016\/j.pharmthera.2016.06.009_bb0020","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1111\/all.12708","article-title":"Treatment with anti-OX40L or anti-TSLP does not alter the frequency of T regulatory cells in allergic asthmatics","volume":"70","author":"Baatjes","year":"2015","journal-title":"Allergy"},{"issue":"4","key":"10.1016\/j.pharmthera.2016.06.009_bb0025","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.jaci.2013.05.012","article-title":"IL-33 is more potent than IL-25 in provoking IL-13-producing nuocytes (type 2 innate lymphoid cells) and airway contraction","volume":"132","author":"Barlow","year":"2013","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.pharmthera.2016.06.009_bb0030","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1378\/chest.91.2.233","article-title":"Use of the protected specimen brush in patients with endotracheal or tracheostomy tubes","volume":"91","author":"Baughman","year":"1987","journal-title":"Chest"},{"issue":"256","key":"10.1016\/j.pharmthera.2016.06.009_bb0035","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3009124","article-title":"Rhinovirus-induced IL-25 in asthma exacerbation drives type 2 immunity and allergic pulmonary inflammation","volume":"6","author":"Beale","year":"2014","journal-title":"Sci Transl Med"},{"issue":"19","key":"10.1016\/j.pharmthera.2016.06.009_bb0040","doi-asserted-by":"crossref","first-page":"10191","DOI":"10.1128\/JVI.00892-10","article-title":"Functional divergence among CD103+ dendritic cell subpopulations following pulmonary poxvirus infection","volume":"84","author":"Beauchamp","year":"2010","journal-title":"J Virol"},{"issue":"8","key":"10.1016\/j.pharmthera.2016.06.009_bb0045","doi-asserted-by":"crossref","first-page":"L816","DOI":"10.1152\/ajplung.00319.2014","article-title":"Pulmonary CD103 expression regulates airway inflammation in asthma","volume":"308","author":"Bernatchez","year":"2015","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"6071","key":"10.1016\/j.pharmthera.2016.06.009_bb0050","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1126\/science.1215418","article-title":"The alarmin interleukin-33 drives protective antiviral CD8(+) T cell responses","volume":"335","author":"Bonilla","year":"2012","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.pharmthera.2016.06.009_bb0055","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.pupt.2010.10.004","article-title":"dsRNA-induced expression of thymic stromal lymphopoietin (TSLP) in asthmatic epithelial cells is inhibited by a small airway relaxant","volume":"24","author":"Brandelius","year":"2011","journal-title":"Pulm Pharmacol Ther"},{"issue":"9","key":"10.1016\/j.pharmthera.2016.06.009_bb0060","doi-asserted-by":"crossref","first-page":"3967","DOI":"10.1172\/JCI65570","article-title":"Long-term IL-33-producing epithelial progenitor cells in chronic obstructive lung disease","volume":"123","author":"Byers","year":"2013","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.pharmthera.2016.06.009_bb0065","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1165\/ajrcmb.26.3.4684","article-title":"Modulation of cadherin and catenins expression by tumor necrosis factor-alpha and dexamethasone in human bronchial epithelial cells","volume":"26","author":"Carayol","year":"2002","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"1","key":"10.1016\/j.pharmthera.2016.06.009_bb0070","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1073\/pnas.0606854104","article-title":"IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo","volume":"104","author":"Carriere","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"10.1016\/j.pharmthera.2016.06.009_bb0075","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/ni.2045","article-title":"Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity","volume":"12","author":"Chang","year":"2011","journal-title":"Nat Immunol"},{"issue":"8","key":"10.1016\/j.pharmthera.2016.06.009_bb0080","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1164\/rccm.201104-0655OC","article-title":"Topographical continuity of bacterial populations in the healthy human respiratory tract","volume":"184","author":"Charlson","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.pharmthera.2016.06.009_bb0085","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1164\/rccm.201403-0505OC","article-title":"Epithelial interleukin-25 is a key mediator in Th2-high, corticosteroid-responsive asthma","volume":"190","author":"Cheng","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.pharmthera.2016.06.009_bb0090","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/j.jaci.2008.04.005","article-title":"A novel IL-1 family cytokine, IL-33, potently activates human eosinophils","volume":"121","author":"Cherry","year":"2008","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.pharmthera.2016.06.009_bb0095","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/cmi.2009.106","article-title":"Intracellular signaling mechanisms regulating the activation of human eosinophils by the novel Th2 cytokine IL-33: Implications for allergic inflammation","volume":"7","author":"Chow","year":"2010","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.pharmthera.2016.06.009_bb0100","doi-asserted-by":"crossref","first-page":"8327","DOI":"10.1038\/ncomms9327","article-title":"Oxidation of the alarmin IL-33 regulates ST2-dependent inflammation","volume":"6","author":"Cohen","year":"2015","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.pharmthera.2016.06.009_bb0105","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1476-7961-10-8","article-title":"IL-3 and TNFalpha increase thymic stromal lymphopoietin receptor (TSLPR) expression on eosinophils and enhance TSLP-stimulated degranulation","volume":"10","author":"Cook","year":"2012","journal-title":"Clin Mol Allergy"},{"issue":"1","key":"10.1016\/j.pharmthera.2016.06.009_bb0110","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jaci.2011.03.043","article-title":"Allergen-induced expression of IL-25 and IL-25 receptor in atopic asthmatic airways and late-phase cutaneous responses","volume":"128","author":"Corrigan","year":"2011","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.pharmthera.2016.06.009_bb0115","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1073\/pnas.1014241108","article-title":"T-helper cell type 2 (Th2) memory T cell-potentiating cytokine IL-25 has the potential to promote angiogenesis in asthma","volume":"108","author":"Corrigan","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Suppl. 5","key":"10.1016\/j.pharmthera.2016.06.009_bb0120","doi-asserted-by":"crossref","first-page":"S244","DOI":"10.1513\/AnnalsATS.201407-304AW","article-title":"Epithelial barrier function and immunity in asthma","volume":"11","author":"Davies","year":"2014","journal-title":"Ann Am Thorac Soc"},{"issue":"4","key":"10.1016\/j.pharmthera.2016.06.009_bb0125","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1084\/jem.20091627","article-title":"Peripheral CD103+ dendritic cells form a unified subset developmentally related to CD8alpha+conventional dendritic cells","volume":"207","author":"Edelson","year":"2010","journal-title":"J Exp Med"},{"issue":"2","key":"10.1016\/j.pharmthera.2016.06.009_bb0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0016384","article-title":"Analysis of the lung microbiome in the \u201chealthy\u201d smoker and in COPD","volume":"6","author":"Erb-Downward","year":"2011","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.pharmthera.2016.06.009_bb0135","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/all.12309","article-title":"IL-33 is a mediator rather than a trigger of the acute allergic response in humans","volume":"69","author":"Fux","year":"2014","journal-title":"Allergy"},{"issue":"3","key":"10.1016\/j.pharmthera.2016.06.009_bb0140","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1183\/13993003.00536-2015","article-title":"Allergen-induced airway responses","volume":"46","author":"Gauvreau","year":"2015","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.pharmthera.2016.06.009_bb0145","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1164\/ajrccm.161.5.9908090","article-title":"Increased numbers of both airway basophils and mast cells in sputum after allergen inhalation challenge of atopic asthmatics","volume":"161","author":"Gauvreau","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"issue":"22","key":"10.1016\/j.pharmthera.2016.06.009_bb0150","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1056\/NEJMoa1402895","article-title":"Effects of an anti-TSLP antibody on allergen-induced asthmatic responses","volume":"370","author":"Gauvreau","year":"2014","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.pharmthera.2016.06.009_bb0155","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s11882-013-0344-1","article-title":"Virus\/allergen interactions in asthma","volume":"13","author":"Gavala","year":"2013","journal-title":"Curr Allergy Asthma Rep"},{"issue":"5","key":"10.1016\/j.pharmthera.2016.06.009_bb0160","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1378\/chest.119.5.1329","article-title":"Heterogeneity of airway inflammation in persistent asthma: Evidence of neutrophilic inflammation and increased sputum interleukin-8","volume":"119","author":"Gibson","year":"2001","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.pharmthera.2016.06.009_bb0165","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.immuni.2011.12.020","article-title":"Lung natural helper cells are a critical source of Th2 cell-type cytokines in protease allergen-induced airway inflammation","volume":"36","author":"Halim","year":"2012","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.pharmthera.2016.06.009_bb0170","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/nm.1946","article-title":"House dust mite allergen induces asthma via Toll-like receptor 4 triggering of airway structural cells","volume":"15","author":"Hammad","year":"2009","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.pharmthera.2016.06.009_bb0175","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1073\/pnas.1315854111","article-title":"IL-25 and type 2 innate lymphoid cells induce pulmonary fibrosis","volume":"111","author":"Hams","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.pharmthera.2016.06.009_bb0180","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1165\/rcmb.2008-0041OC","article-title":"Functional analysis of the thymic stromal lymphopoietin variants in human bronchial epithelial cells","volume":"40","author":"Harada","year":"2009","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"6","key":"10.1016\/j.pharmthera.2016.06.009_bb0185","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1165\/rcmb.2009-0418OC","article-title":"Thymic stromal lymphopoietin gene promoter polymorphisms are associated with susceptibility to bronchial asthma","volume":"44","author":"Harada","year":"2011","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"2","key":"10.1016\/j.pharmthera.2016.06.009_bb0190","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/eji.201242863","article-title":"IL-33 citrine reporter mice reveal the temporal and spatial expression of IL-33 during allergic lung inflammation","volume":"43","author":"Hardman","year":"2013","journal-title":"Eur J Immunol"},{"issue":"4","key":"10.1016\/j.pharmthera.2016.06.009_bb0195","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1183\/09031936.00065809","article-title":"Characterisation of cell adhesion in airway epithelial cell types using electric cell-substrate impedance sensing","volume":"35","author":"Heijink","year":"2010","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.pharmthera.2016.06.009_bb0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008578","article-title":"Disordered microbial communities in asthmatic airways","volume":"5","author":"Hilty","year":"2010","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.pharmthera.2016.06.009_bb0205","doi-asserted-by":"crossref","first-page":"4208","DOI":"10.1172\/JCI67119","article-title":"Common genetic variation at the IL1RL1 locus regulates IL-33\/ST2 signaling","volume":"123","author":"Ho","year":"2013","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.pharmthera.2016.06.009_bb0210","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1159\/000235107","article-title":"A contiguous network of dendritic antigen-presenting cells within the respiratory epithelium","volume":"91","author":"Holt","year":"1990","journal-title":"Int Arch Allergy Appl Immunol"},{"issue":"7","key":"10.1016\/j.pharmthera.2016.06.009_bb0215","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.4049\/jimmunol.1201224","article-title":"Inducible IL-33 expression by mast cells is regulated by a calcium-dependent pathway","volume":"189","author":"Hsu","year":"2012","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.pharmthera.2016.06.009_bb0220","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.4049\/jimmunol.180.4.2443","article-title":"IL-33, a potent inducer of adaptive immunity to intestinal nematodes","volume":"180","author":"Humphreys","year":"2008","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.pharmthera.2016.06.009_bb0225","doi-asserted-by":"crossref","first-page":"443","DOI":"10.4049\/jimmunol.169.1.443","article-title":"New IL-17 family members promote Th1 or Th2 responses in the lung: In vivo function of the novel cytokine IL-25","volume":"169","author":"Hurst","year":"2002","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.pharmthera.2016.06.009_bb0230","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/intimm\/dxr113","article-title":"Thymic stromal lymphopoietin (TSLP)-induced polyclonal B-cell activation and autoimmunity are mediated by CD4+ T cells and IL-4","volume":"24","author":"Iseki","year":"2012","journal-title":"Int Immunol"},{"issue":"9","key":"10.1016\/j.pharmthera.2016.06.009_bb0235","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1084\/jem.20051135","article-title":"TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand","volume":"202","author":"Ito","year":"2005","journal-title":"J Exp Med"},{"issue":"12","key":"10.1016\/j.pharmthera.2016.06.009_bb0240","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1164\/rccm.201406-1039OC","article-title":"IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivo","volume":"190","author":"Jackson","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.pharmthera.2016.06.009_bb0245","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.immuni.2007.08.015","article-title":"Disruption of E-cadherin-mediated adhesion induces a functionally distinct pathway of dendritic cell maturation","volume":"27","author":"Jiang","year":"2007","journal-title":"Immunity"},{"issue":"4 Pt 2","key":"10.1016\/j.pharmthera.2016.06.009_bb0250","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1164\/ajrccm\/152.4_Pt_2.S46","article-title":"Natural and experimental rhinovirus infections of the lower respiratory tract","volume":"152","author":"Johnston","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.pharmthera.2016.06.009_bb0255","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1378\/chest.08-1595","article-title":"Association of IL-17RB gene polymorphism with asthma","volume":"135","author":"Jung","year":"2009","journal-title":"Chest"},{"issue":"9","key":"10.1016\/j.pharmthera.2016.06.009_bb0260","doi-asserted-by":"crossref","first-page":"4489","DOI":"10.4049\/jimmunol.1201212","article-title":"IL-33-mediated innate response and adaptive immune cells contribute to maximum responses of protease allergen-induced allergic airway inflammation","volume":"190","author":"Kamijo","year":"2013","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.pharmthera.2016.06.009_bb0265","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.4049\/jimmunol.179.2.1080","article-title":"TLR3- and Th2 cytokine-dependent production of thymic stromal lymphopoietin in human airway epithelial cells","volume":"179","author":"Kato","year":"2007","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.pharmthera.2016.06.009_bb0270","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/all.12593","article-title":"IL-33 drives airway hyper-responsiveness through IL-13-mediated mast cell: Airway smooth muscle crosstalk","volume":"70","author":"Kaur","year":"2015","journal-title":"Allergy"},{"issue":"5","key":"10.1016\/j.pharmthera.2016.06.009_bb0275","doi-asserted-by":"crossref","first-page":"383","DOI":"10.2174\/1871528110908050383","article-title":"Role of interleukin-17F in asthma","volume":"8","author":"Kawaguchi","year":"2009","journal-title":"Inflamm Allergy Drug Targets"},{"issue":"3","key":"10.1016\/j.pharmthera.2016.06.009_bb0280","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.immuni.2015.02.011","article-title":"Cigarette smoke silences innate lymphoid cell function and facilitates an exacerbated type I interleukin-33-dependent response to infection","volume":"42","author":"Kearley","year":"2015","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.pharmthera.2016.06.009_bb0285","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1182\/blood-2002-01-0012","article-title":"Transgenic overexpression of human IL-17E results in eosinophilia, B-lymphocyte hyperplasia, and altered antibody production","volume":"100","author":"Kim","year":"2002","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.pharmthera.2016.06.009_bb0290","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1164\/ajrccm\/136.2.379","article-title":"Bronchoalveolar cell profiles of asthmatic and nonasthmatic subjects","volume":"136","author":"Kirby","year":"1987","journal-title":"Am Rev Respir Dis"},{"issue":"2","key":"10.1016\/j.pharmthera.2016.06.009_bb0295","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.4049\/jimmunol.0900904","article-title":"Proteases induce production of thymic stromal lymphopoietin by airway epithelial cells through protease-activated receptor-2","volume":"183","author":"Kouzaki","year":"2009","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.pharmthera.2016.06.009_bb0300","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1165\/rcmb.2012-0304OC","article-title":"Transcription of interleukin-25 and extracellular release of the protein is regulated by allergen proteases in airway epithelial cells","volume":"49","author":"Kouzaki","year":"2013","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"6","key":"10.1016\/j.pharmthera.2016.06.009_bb0305","doi-asserted-by":"crossref","first-page":"a001651","DOI":"10.1101\/cshperspect.a001651","article-title":"The nuclear factor NF-kappaB pathway in inflammation","volume":"1","author":"Lawrence","year":"2009","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"2","key":"10.1016\/j.pharmthera.2016.06.009_bb0310","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3109\/01902148.2013.870261","article-title":"Blockade of IL-33\/ST2 ameliorates airway inflammation in a murine model of allergic asthma","volume":"40","author":"Lee","year":"2014","journal-title":"Exp Lung Res"},{"issue":"5","key":"10.1016\/j.pharmthera.2016.06.009_bb0315","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1073\/pnas.1115884109","article-title":"IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G","volume":"109","author":"Lefrancais","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.pharmthera.2016.06.009_bb0320","doi-asserted-by":"crossref","first-page":"677","DOI":"10.4049\/jimmunol.162.2.677","article-title":"Thymic stromal lymphopoietin: A cytokine that promotes the development of IgM+ B cells in vitro and signals via a novel mechanism","volume":"162","author":"Levin","year":"1999","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.pharmthera.2016.06.009_bb0325","first-page":"23","article-title":"Regulation of interleukin 33\/ST2 signaling of human corneal epithelium in allergic diseases","volume":"6","author":"Lin","year":"2013","journal-title":"Int J Ophthalmol"},{"issue":"2","key":"10.1016\/j.pharmthera.2016.06.009_bb0330","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1084\/jem.20051745","article-title":"Thymic stromal lymphopoietin: Master switch for allergic inflammation","volume":"203","author":"Liu","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.pharmthera.2016.06.009_bb0335","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.coi.2015.02.001","article-title":"Epithelial cytokines and pulmonary allergic inflammation","volume":"34c","author":"Lloyd","year":"2015","journal-title":"Curr Opin Immunol"},{"issue":"6","key":"10.1016\/j.pharmthera.2016.06.009_bb0340","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.smim.2013.10.006","article-title":"Special aspects of interleukin-33 and the IL-33 receptor complex","volume":"25","author":"Martin","year":"2013","journal-title":"Semin Immunol"},{"issue":"3","key":"10.1016\/j.pharmthera.2016.06.009_bb0345","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.it.2015.01.005","article-title":"Lung ILC2s link innate and adaptive responses in allergic inflammation","volume":"36","author":"Martinez-Gonzalez","year":"2015","journal-title":"Trends Immunol"},{"issue":"1","key":"10.1016\/j.pharmthera.2016.06.009_bb0350","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/2045-7022-1-5","article-title":"Allergy as an epithelial barrier disease","volume":"1","author":"Mattila","year":"2011","journal-title":"Clin Transl Allergy"},{"issue":"3 Suppl.","key":"10.1016\/j.pharmthera.2016.06.009_bb0355","doi-asserted-by":"crossref","first-page":"27s","DOI":"10.1378\/chest.101.3_Supplement.27S","article-title":"Expression of the potent inflammatory cytokines, GM-CSF, IL6, and IL8, in bronchial epithelial cells of asthmatic patients","volume":"101","author":"Mattoli","year":"1992","journal-title":"Chest"},{"issue":"24","key":"10.1016\/j.pharmthera.2016.06.009_bb0360","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMoa1315231","article-title":"Brodalumab, an anti-IL17RA monoclonal antibody, in psoriatic arthritis","volume":"370","author":"Mease","year":"2014","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.pharmthera.2016.06.009_bb0365","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/imm.12071","article-title":"Interleukin-33 and alveolar macrophages contribute to the mechanisms underlying the exacerbation of IgE-mediated airway inflammation and remodelling in mice","volume":"139","author":"Mizutani","year":"2013","journal-title":"Immunology"},{"issue":"11","key":"10.1016\/j.pharmthera.2016.06.009_bb0370","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/ni.2104","article-title":"Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161","volume":"12","author":"Mjosberg","year":"2011","journal-title":"Nat Immunol"},{"issue":"13","key":"10.1016\/j.pharmthera.2016.06.009_bb0375","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1056\/NEJMoa0906312","article-title":"A large-scale, consortium-based genomewide association study of asthma","volume":"363","author":"Moffatt","year":"2010","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.pharmthera.2016.06.009_bb0380","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1038\/ni.2131","article-title":"Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus","volume":"12","author":"Monticelli","year":"2011","journal-title":"Nat Immunol"},{"issue":"10","key":"10.1016\/j.pharmthera.2016.06.009_bb0385","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0003331","article-title":"The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel 'alarmin'?","volume":"3","author":"Moussion","year":"2008","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.pharmthera.2016.06.009_bb0390","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1136\/thx.2005.042523","article-title":"Study of modifiable risk factors for asthma exacerbations: virus infection and allergen exposure increase the risk of asthma hospital admissions in children","volume":"61","author":"Murray","year":"2006","journal-title":"Thorax"},{"issue":"7293","key":"10.1016\/j.pharmthera.2016.06.009_bb0395","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/nature08900","article-title":"Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity","volume":"464","author":"Neill","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2016.06.009_bb0400","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s40064-016-1673-z","article-title":"Measuring serum concentrations of interleukin-33 in atopic dermatitis is associated with potential false positive results","volume":"5","author":"Nygaard","year":"2016","journal-title":"SpringerPlus"},{"issue":"2","key":"10.1016\/j.pharmthera.2016.06.009_bb0405","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1183\/09031936.00121008","article-title":"FcepsilonRI-mediated thymic stromal lymphopoietin production by interleukin-4-primed human mast cells","volume":"34","author":"Okayama","year":"2009","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.pharmthera.2016.06.009_bb0410","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.4049\/jimmunol.178.3.1396","article-title":"Induction of IL-4 expression in CD4(+) T cells by thymic stromal lymphopoietin","volume":"178","author":"Omori","year":"2007","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.pharmthera.2016.06.009_bb0415","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.jaci.2010.08.041","article-title":"Mechanical injury polarizes skin dendritic cells to elicit a T(H)2 response by inducing cutaneous thymic stromal lymphopoietin expression","volume":"126","author":"Oyoshi","year":"2010","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.pharmthera.2016.06.009_bb0420","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nrrheum.2011.53","article-title":"Interleukin-33 biology with potential insights into human diseases","volume":"7","author":"Palmer","year":"2011","journal-title":"Nat Rev Rheumatol"},{"issue":"3","key":"10.1016\/j.pharmthera.2016.06.009_bb0425","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.cyto.2008.03.008","article-title":"The IL-1 receptor accessory protein (AcP) is required for IL-33 signaling and soluble AcP enhances the ability of soluble ST2 to inhibit IL-33","volume":"42","author":"Palmer","year":"2008","journal-title":"Cytokine"},{"key":"10.1016\/j.pharmthera.2016.06.009_bb0430","article-title":"Airway responses towards allergens \u2014 From the airway epithelium to T cells","author":"Papazian","year":"2014","journal-title":"Clin Exp Allergy"},{"issue":"5","key":"10.1016\/j.pharmthera.2016.06.009_bb0435","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.humimm.2012.11.002","article-title":"Association of single nucleotide polymorphisms on Interleukin 17 receptor A (IL17RA) gene with aspirin hypersensitivity in asthmatics","volume":"74","author":"Park","year":"2013","journal-title":"Hum Immunol"},{"issue":"7","key":"10.1016\/j.pharmthera.2016.06.009_bb0440","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1182\/blood-2008-05-157818","article-title":"Human basophils and eosinophils are the direct target leukocytes of the novel IL-1 family member IL-33","volume":"113","author":"Pecaric-Petkovic","year":"2009","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.pharmthera.2016.06.009_bb0445","doi-asserted-by":"crossref","first-page":"5094","DOI":"10.4049\/jimmunol.0802387","article-title":"Increased expression of IL-33 in severe asthma: Evidence of expression by airway smooth muscle cells","volume":"183","author":"Prefontaine","year":"2009","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.pharmthera.2016.06.009_bb0450","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.jaci.2009.12.935","article-title":"Increased IL-33 expression by epithelial cells in bronchial asthma","volume":"125","author":"Prefontaine","year":"2010","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.pharmthera.2016.06.009_bb0455","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/eji.201343862","article-title":"Regulation of the tolerogenic function of steady-state DCs","volume":"44","author":"Probst","year":"2014","journal-title":"Eur J Immunol"},{"issue":"10","key":"10.1016\/j.pharmthera.2016.06.009_bb0460","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.3109\/02770903.2014.938353","article-title":"Serum levels of IL-10, IL-17F and IL-33 in patients with asthma: A case\u2013control study","volume":"51","author":"Raeiszadeh Jahromi","year":"2014","journal-title":"J Asthma"},{"issue":"1","key":"10.1016\/j.pharmthera.2016.06.009_bb0465","doi-asserted-by":"crossref","first-page":"336","DOI":"10.4049\/jimmunol.167.1.336","article-title":"Human thymic stromal lymphopoietin preferentially stimulates myeloid cells","volume":"167","author":"Reche","year":"2001","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.pharmthera.2016.06.009_bb0470","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1183\/13993003.00853-2015","article-title":"A summary of the new GINA strategy: A roadmap to asthma control","volume":"46","author":"Reddel","year":"2015","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.pharmthera.2016.06.009_bb0475","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1136\/annrheumdis-2015-208557","article-title":"Pitfalls for detecting interleukin-33 by ELISA in the serum of patients with primary Sjogren syndrome: comparison of different kits","volume":"75","author":"Riviere","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.pharmthera.2016.06.009_bb0480","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1056\/NEJM199201303260504","article-title":"Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma","volume":"326","author":"Robinson","year":"1992","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.pharmthera.2016.06.009_bb0485","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.toxlet.2005.10.013","article-title":"Interactions between dendritic cells and epithelial cells in allergic disease","volume":"162","author":"Roggen","year":"2006","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.pharmthera.2016.06.009_bb0490","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2015.03.039","article-title":"Thymic stromal lymphopoietin activation of basophils in patients with allergic asthma is IL-3 dependent","author":"Salter","year":"2015","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.pharmthera.2016.06.009_bb0495","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jaci.2013.12.1080","article-title":"Association of IL33-IL-1 receptor-like 1 (IL1RL1) pathway polymorphisms with wheezing phenotypes and asthma in childhood","volume":"134","author":"Savenije","year":"2014","journal-title":"J Allergy Clin Immunol"},{"issue":"7519","key":"10.1016\/j.pharmthera.2016.06.009_bb0500","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/nature13577","article-title":"The alarmin IL-33 promotes regulatory T-cell function in the intestine","volume":"513","author":"Schiering","year":"2014","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.pharmthera.2016.06.009_bb0505","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1136\/gutjnl-2011-301785","article-title":"Neutralisation of the interleukin-33\/ST2 pathway ameliorates experimental colitis through enhancement of mucosal healing in mice","volume":"62","author":"Sedhom","year":"2013","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.pharmthera.2016.06.009_bb0510","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.jaci.2010.01.044","article-title":"Thymic stromal lymphopoietin-induced human asthmatic airway epithelial cell proliferation through an IL-13-dependent pathway","volume":"125","author":"Semlali","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.pharmthera.2016.06.009_bb0515","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2015.01.003","article-title":"IL-25 as a novel therapeutic target in nasal polyps of patients with chronic rhinosinusitis","author":"Shin","year":"2015","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.pharmthera.2016.06.009_bb0520","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1440-1843.2006.00784.x","article-title":"Inflammatory subtypes in asthma: Assessment and identification using induced sputum","volume":"11","author":"Simpson","year":"2006","journal-title":"Respirology"},{"key":"10.1016\/j.pharmthera.2016.06.009_bb0525","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2014.12.1918","article-title":"Thymic stromal lymphopoietin and IL-33 modulate migration of hematopoietic progenitor cells in patients with allergic asthma","author":"Smith","year":"2015","journal-title":"J Allergy Clin Immunol"},{"issue":"8","key":"10.1016\/j.pharmthera.2016.06.009_bb0530","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/intimm\/dxn060","article-title":"IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cells","volume":"20","author":"Smithgall","year":"2008","journal-title":"Int Immunol"},{"issue":"3","key":"10.1016\/j.pharmthera.2016.06.009_bb0535","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/ni1558","article-title":"A mechanism for the initiation of allergen-induced T helper type 2 responses","volume":"9","author":"Sokol","year":"2008","journal-title":"Nat Immunol"},{"issue":"5","key":"10.1016\/j.pharmthera.2016.06.009_bb0540","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1136\/thx.51.5.496","article-title":"Relationship between the inflammatory infiltrate in bronchial biopsy specimens and clinical severity of asthma in patients treated with inhaled steroids","volume":"51","author":"Sont","year":"1996","journal-title":"Thorax"},{"issue":"8\u20139","key":"10.1016\/j.pharmthera.2016.06.009_bb0545","first-page":"692","article-title":"Thymic stromal lymphopoietin (TSLP): A pivotal role in allergic immune responses","volume":"23","author":"Soumelis","year":"2007","journal-title":"Med Sci"},{"issue":"9","key":"10.1016\/j.pharmthera.2016.06.009_bb0550","doi-asserted-by":"crossref","first-page":"5981","DOI":"10.4049\/jimmunol.181.9.5981","article-title":"An IL-1 cytokine member, IL-33, induces human basophil activation via its ST2 receptor","volume":"181","author":"Suzukawa","year":"2008","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.pharmthera.2016.06.009_bb0555","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1159\/000355331","article-title":"IL-25 and IL-25 receptor expression on eosinophils from subjects with allergic asthma","volume":"163","author":"Tang","year":"2014","journal-title":"Int Arch Allergy Immunol"},{"issue":"7","key":"10.1016\/j.pharmthera.2016.06.009_bb0560","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1056\/NEJMra1301758","article-title":"Occupational asthma","volume":"370","author":"Tarlo","year":"2014","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.pharmthera.2016.06.009_bb0565","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1124\/jpet.114.222505","article-title":"Targeting IL-33 in autoimmunity and inflammation","volume":"354","author":"Theoharides","year":"2015","journal-title":"J Pharmacol Exp Ther"},{"issue":"7","key":"10.1016\/j.pharmthera.2016.06.009_bb0570","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1136\/thx.2009.125930","article-title":"Double-stranded RNA induces disproportionate expression of thymic stromal lymphopoietin versus interferon-beta in bronchial epithelial cells from donors with asthma","volume":"65","author":"Uller","year":"2010","journal-title":"Thorax"},{"issue":"6","key":"10.1016\/j.pharmthera.2016.06.009_bb0575","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1158\/0008-5472.CAN-13-2729","article-title":"Alarmin IL-33 acts as an immunoadjuvant to enhance antigen-specific tumor immunity","volume":"74","author":"Villarreal","year":"2014","journal-title":"Cancer Res"},{"issue":"7","key":"10.1016\/j.pharmthera.2016.06.009_bb0580","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1517\/14728222.2014.915314","article-title":"Thymic stromal lymphopoietin: A central regulator of allergic asthma","volume":"18","author":"Watson","year":"2014","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.pharmthera.2016.06.009_bb0585","doi-asserted-by":"crossref","DOI":"10.1165\/rcmb.2015-0038OC","article-title":"IL-17RA signaling drives airway inflammation and bronchial hyper reactivity in allergic asthma","author":"Willis","year":"2015","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"3","key":"10.1016\/j.pharmthera.2016.06.009_bb0590","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1165\/rcmb.2009-0168OC","article-title":"Thymic stromal lymphopoietin induces chemotactic and prosurvival effects in eosinophils: implications in allergic inflammation","volume":"43","author":"Wong","year":"2010","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"2","key":"10.1016\/j.pharmthera.2016.06.009_bb0595","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jaci.2010.05.024","article-title":"Thymic stromal lymphopoietin-activated invariant natural killer T cells trigger an innate allergic immune response in atopic dermatitis","volume":"126","author":"Wu","year":"2010","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.pharmthera.2016.06.009_bb0600","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.jaci.2011.05.038","article-title":"Defective epithelial barrier function in asthma","volume":"128","author":"Xiao","year":"2011","journal-title":"J Allergy Clin Immunol"},{"issue":"10","key":"10.1016\/j.pharmthera.2016.06.009_bb0605","doi-asserted-by":"crossref","first-page":"5743","DOI":"10.4049\/jimmunol.0903818","article-title":"IL-33 mediates inflammatory responses in human lung tissue cells","volume":"185","author":"Yagami","year":"2010","journal-title":"J Immunol"},{"issue":"11","key":"10.1016\/j.pharmthera.2016.06.009_bb0610","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.1002\/eji.201141629","article-title":"IL-33 synergizes with TCR and IL-12 signaling to promote the effector function of CD8+ T cells","volume":"41","author":"Yang","year":"2011","journal-title":"Eur J Immunol"},{"issue":"4","key":"10.1016\/j.pharmthera.2016.06.009_bb0615","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.4049\/jimmunol.181.4.2790","article-title":"Expression and cellular provenance of thymic stromal lymphopoietin and chemokines in patients with severe asthma and chronic obstructive pulmonary disease","volume":"181","author":"Ying","year":"2008","journal-title":"J Immunol"},{"issue":"12","key":"10.1016\/j.pharmthera.2016.06.009_bb0620","doi-asserted-by":"crossref","first-page":"8183","DOI":"10.4049\/jimmunol.174.12.8183","article-title":"Thymic stromal lymphopoietin expression is increased in asthmatic airways and correlates with expression of Th2-attracting chemokines and disease severity","volume":"174","author":"Ying","year":"2005","journal-title":"J Immunol"},{"issue":"308","key":"10.1016\/j.pharmthera.2016.06.009_bb0625","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aab0166","article-title":"ST2 blockade reduces sST2-producing T cells while maintaining protective mST2-expressing T cells during graft-versus-host disease","volume":"7","author":"Zhang","year":"2015","journal-title":"Sci Transl Med"},{"issue":"2","key":"10.1016\/j.pharmthera.2016.06.009_bb0630","doi-asserted-by":"crossref","first-page":"L375","DOI":"10.1152\/ajplung.00045.2007","article-title":"Constitutive and inducible thymic stromal lymphopoietin expression in human airway smooth muscle cells: Role in chronic obstructive pulmonary disease","volume":"293","author":"Zhang","year":"2007","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"3","key":"10.1016\/j.pharmthera.2016.06.009_bb0635","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/cea.12683","article-title":"The interleukin-33 receptor ST2 is important for the development of peripheral airway hyperresponsiveness and inflammation in a house dust mite mouse model of asthma","volume":"46","author":"Zoltowska","year":"2016","journal-title":"Clin Exp Allergy"}],"container-title":["Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725816300997?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725816300997?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T21:43:14Z","timestamp":1692394994000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725816300997"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":127,"alternative-id":["S0163725816300997"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2016.06.009","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biologics and the lung: TSLP and other epithelial cell-derived cytokines in asthma","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2016.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}